SHIELDED LIVING THERAPEUTICS™

Our Purpose

Patients with diseases such as diabetes or lysosomal diseases often are treated with frequent injections or infusions — sometimes multiple times daily — and constant, lifelong vigilance to manage their disease.

We are developing our Shielded Living Therapeutics™ platform to address these treatment challenges. Leveraging advances in cell differentiation and engineering, together with cutting-edge innovations in our proprietary biocompatible materials, we are designing product candidates to provide a wide range of functions or therapeutic molecules that may be missing or deficient in the body—potentially resulting in functional cures for patients with a wide range of acute and chronic diseases.